There is no clear information available in the provided sources regarding the maximum number of Vascepa refills. However, we can gather some relevant information from these sources.

Vascepa is a prescription medication that contains icosapent ethyl and is used to treat high levels of triglycerides in the blood. According to the first source [1], Vascepa is a brand-name drug that is currently under patent protection, which means that only the manufacturer has the right to sell it. The patent for Vascepa is set to expire in 2030.

The second source [2] provides a list of medications covered by the New York State Medicaid program. Vascepa is included in this list, which means that Medicaid beneficiaries in New York can get coverage for this medication. However, the source does not provide any information on the maximum number of refills allowed for Vascepa.

The third source [3] is a document from the British Columbia Ministry of Health that provides information on the maximum number of refills allowed for certain medications. However, this document does not mention Vascepa.

In conclusion, based on the provided sources, there is no clear information available regarding the maximum number of Vascepa refills. It is best to consult with a healthcare provider or a pharmacist for more information on the prescription and refills of Vascepa.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf
[3] https://www2.gov.bc.ca/assets/gov/health/health-drug-coverage/pharmacare/pad_refills_oct_2022_statins_v1.pdf